Characterization and Epitope Mapping of Neutralizing Monoclonal Antibodies Produced by Immunization with Oligomeric Simian Immunodeficiency Virus Envelope Protein

Keywords

Computer science

References

• Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodiesWairimu Pauline Wainaina — 1994
• A novel, glycan-dependent epitope in the V2 domain of human immunodeficiency virus type 1 gp120 is recognized by a highly potent, neutralizing chimpanzee monoclonal antibodyH.A. Videla, Marisa Viera, P.S. Guiamet — 1994
• Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virusEkaterina Evdokimova — 1994
• The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.Paul W.H.I. Parren, John P. Moore, Dennis R. Burton — 1999
• HIV–1 neutralizing antibodies: How full is the bottle?John P. Moore, Dennis R. Burton — 1999
• Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humansJohn P. Moore, David D. Ho — 1993
• Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralizationAtsushi Koito, Greg Harrowe, Jay A. Levy — 1994
• Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDSJulie Overbaugh, Lyle M. Rudensey, Mark Papenhausen — 1991
• Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding virusesBenjamin K. Chen, Kalle Saksela, Raul Andino — 1994
• Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.C K Leonard, Michael W. Spellman, L Riddle — 1990
• Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoproteinC Shotton, Cath Arnold, Quentin J. Sattentau — 1995
• Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodiesJohn R. Mascola, Gabriela Stiegler, Thomas C. VanCott — 2000
• Simian Immunodeficiency Virus (SIV) Envelope-Specific Fabs with High-Level Homologous Neutralizing Activity: Recovery from a Long-Term-Nonprogressor SIV-Infected MacaqueJoakim Glamann, Dennis R. Burton, Paul W.H.I. Parren — 1998
• Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domainsJohn P. Moore, Quentin J. Sattentau, Hironori Yoshiyama — 1993
• The "V3" domain is a determinant of simian immunodeficiency virus cell tropismFrank Kirchhoff, Kazuyasu Mori, Ronald C. Desrosiers — 1994
• Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120Michael Fung, Chengyu Sun, Wayne L. Gordon — 1992
• Vaccines and the induction of functional antibodies: Time to look beyond the molecules of natural infection?Dennis R. Burton, Paul W.H.I. Parren — 2000
• Functional Dissection of CCR5 Coreceptor Function through the Use of CD4-Independent Simian Immunodeficiency Virus StrainsAimee L. Edinger, Cédric Blanpain, Kevin Kunstman — 1999
• Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infectionTimothy W. Baba, Vladimír Liška, Regina Hofmann‐Lehmann — 2000
• A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1Thomas Muster, Franz Steindl, Martin Purtscher — 1993

Cited by

• Simian immunodeficiency virus encephalitis: analysis of envelope sequences from individual brain multinucleated giant cells and tissue samples.正俊 門脇 — 2002
• Characterization and Enhanced Processing of Soluble, Oligomeric gp140 Envelope Glycoproteins Derived from Human Immunodeficiency Virus Type-1 Primary IsolatesAgnes Jones-Trower — 2001
• Restriction of macrophage infection during HIV and SIV infection: The role of antibodies and coreceptor use plasticity in enforcing CD-dependent entry and shaping tropism in vivoNicholas Francella — 2013
• Electron Microscopy Analysis of Viral MorphogenesisAnnegret Pelchen–Matthews, Mark Marsh — 2007
• CD4+ T Cells Support Production of Simian Immunodeficiency Virus Env Antibodies That Enforce CD4-Dependent Entry and Shape Tropism In VivoNicholas Francella, Sarah Gwyn, Yanjie Yi — 2013
• Importance of the V1/V2 Loop Region of Simian-Human Immunodeficiency Virus Envelope Glycoprotein gp120 in Determining the Strain Specificity of the Neutralizing Antibody ResponseMelissa E. Laird, Tatsuhiko Igarashi, Malcolm A. Martin — 2008
• Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization.Emma T. Crooks, Pengfei Jiang, Michael Franti — 2008
• Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidatesBarton F. Haynes, David C. Montefiori — 2006
• Oligomeric and Conformational Properties of a Proteolytically Mature, Disulfide-Stabilized Human Immunodeficiency Virus Type 1 gp140 Envelope GlycoproteinNorbert Schülke, Mika Vesanen, Rogier W. Sanders — 2002
• HIV fusion and its inhibition.Celia C. LaBranche, Gennaro Galasso, John P. Moore — 2001
• Coreceptor Switch of [MLV(SIVagm)] pseudotype vectors by V3-loop exchange.Stefanie Steidl, Jörn Stitz, Isabel Schmitt — 2002
• Flow Cytometry Based Identification of Simian Immunodeficiency Virus Env-specific B LymphocytesIsmaël Fofana, Arnaud D. Colantonio, R. Keith Reeves — 2011
• Simian Immunodeficiency Virus Infection Evades Vaccine-Elicited Antibody Responses to V2 RegionJia Guo, Teng Zuo, Lin Cheng — 2015
• Molecular Architectures of Trimeric SIV and HIV-1 Envelope Glycoproteins on Intact Viruses: Strain-Dependent Variation in Quaternary StructureTommi White, Alberto Bartesaghi, Mario J. Borgnia — 2010
• Determining the structure of an unliganded and fully glycosylated SIV gp120 envelope glycoprotein.Bing Chen, Erik Vogan, Haiyun Gong — 2005
• Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaquesPhilip J. Santangelo, Kenneth A. Rogers, Chiara Zurla — 2015
• Identification and characterization of a macrophage-tropic SIV envelope glycoprotein variant in blood from early infection in SIVmac251-infected macaques.Po-Jen Yen, Megan Mefford, James A. Hoxie — 2014
• Analysis of a 17-amino acid residue, virus-neutralizing microantibody.Caroline J. Heap, Yuqin Wang, Teresa J. T. Pinheiro — 2005
• Oligomeric structure of virion-associated and soluble forms of the simian immunodeficiency virus envelope protein in the prefusion activated conformationPeter Schuck, Richard D. Leapman, Larry O. Arthur — 2001
• Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.Kelly Stefano Cole, Martha I. Álvarez-Olmos, Debra Elliott — 2001

Related papers

No related papers recorded.